62 results
424B4
BIXT
Bioxytran, Inc
2 Oct 23
Prospectus supplement with pricing info
11:36am
-19 to Evaluate the Safety, Efficacy, and Pharmacokinetics of Orally Administered ProLectin-M”. The trial is planned to start on, or around, October 1 … (PROTECT), a Randomized, Double-blinded Clinical Trial to Evaluate the Efficacy and Safety in Non-Hospitalized Adult Participants with COVID-19
424B4
2vj0z7gffxk1mkg1e2gj
14 Aug 23
Prospectus supplement with pricing info
8:07pm
UPLOAD
fnvby248he04r6d6
29 Jun 23
Letter from SEC
12:00am
8-K
vesvnb0few0hyr2je
8 Dec 22
Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients
7:00am
8-K
EX-99.1
7eddipy x6h
16 Nov 22
Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print
7:00am